Reconcile

RSS

fluoxetine

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for Reconcile. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Reconcile.

For practical information about using Reconcile, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.

This EPAR was last updated on 18/12/2018

Authorisation details

Product details
Name
Reconcile
Agency product number
EMEA/V/C/000133
Active substance
fluoxetine
International non-proprietary name (INN) or common name
fluoxetine
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QN06AB03
Publication details
Marketing-authorisation holder
Nexcyon Pharmaceuticals Ltd
Revision
9
Date of issue of marketing authorisation valid throughout the European Union
08/07/2008
Contact address

Bridge House
2 Bridge Avenue
Maidenhead
Berkshire SL6 1RR
United Kingdom

Product information

05/12/2018 Reconcile - EMEA/V/C/000133 - IAIN/0030

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

PSYCHOANALEPTICS

Therapeutic indication

As an aid in the treatment of separation-related disorders in dogs manifested by destruction and inappropriate behaviours (vocalisation and inappropriate defecation and / or urination) and only in combination with behavioural-modification techniques.

Assessment history

How useful was this page?

Add your rating